Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESOBLAST LTD Capital/Financing Update 2023

Apr 30, 2023

31658_rns_2023-04-30_ef736156-b784-4631-a986-ae6e2e92331d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [178 x 23] intentionally omitted <==

1 May 2023

The Manager Company Notices Section ASX Limited Level 4, North Tower, Rialto Towers 525 Collins Street MELBOURNE VIC 3000

Dear Sir/Madam

Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Mesoblast Limited (ABN 68 109 431 870) ( Mesoblast ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

Mesoblast has today issued 77,083,607 fully paid ordinary shares in Mesoblast (the Shares ) at an issue price of A$0.85 per Share to sophisticated and professional investors under the private placement announced on Wednesday, 26 April 2023.

Mesoblast advises that:

  • 1 the Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

  • 2 this notice is being given under section 708A(5)(e) of the Corporations Act;

  • 3 as at the date of this notice, Mesoblast has complied with:

    • (a) the provisions of Chapter 2M of the Corporations Act, as they apply to Mesoblast; and

    • (b) sections 674 and 674A of the Corporations Act; and

  • 4 as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.

Release authorized by the Chief Executive.

Yours sincerely

==> picture [59 x 47] intentionally omitted <==

Niva Sivakumar Company Secretary Mesoblast Limited